Halozyme Therapeutics, Inc. (HALO)

Last Closing Price: 56.07 (2025-05-30)

Combined Ratio (Quarterly)

Combined Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The combined ratio is calculated by taking the sum of incurred losses and expenses and then dividing them by earned premium. Calculated as: Total Operating Expenses / Net Premiums Earned

Halozyme Therapeutics, Inc. (HALO) Combined Ratio data is not available.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$264.86M
$118.09M
$48.40M
$216.46M
$123.33M
$141.53M
$2.29M
$143.83M
$143.83M
$118.09M
$118.09M
$118.09M
$118.09M
$141.53M
$162.12M
123.22M
126.64M
$0.96
$0.93
Balance Sheet Financials
$1.26B
$72.82M
$934.50M
$2.20B
$150.38M
$1.51B
$1.56B
$1.71B
$482.27M
$-318.62M
$482.27M
123.17M
Cash Flow Statement Financials
$154.22M
$-90.42M
$-3.32M
$115.85M
$176.33M
$60.48M
$10.67M
--
--
Fundamental Metrics & Ratios
8.39
--
--
0.76
3.13
81.73%
53.44%
53.44%
--
54.30%
44.59%
$153.27M
--
--
Combined Ratio
--
0.12
0.29
0.87
103.51
24.49%
-37.06%
5.38%
5.94%
$3.92
$1.21
$1.22